• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

万古霉素耐药和敏感肠球菌菌血症的不同危险因素。

Differing risk factors for vancomycin-resistant and vancomycin-sensitive enterococcal bacteraemia.

机构信息

Department of Infectious Diseases, St Vincent’s Hospital, Victoria, Australia.

出版信息

Clin Microbiol Infect. 2012 Apr;18(4):388-94. doi: 10.1111/j.1469-0691.2011.03591.x. Epub 2011 Aug 16.

DOI:10.1111/j.1469-0691.2011.03591.x
PMID:21848977
Abstract

Enterococcus is an important cause of bacteraemia. Previous epidemiological studies examining risk factors for enterococcal bacteraemia have used traditional case-control study designs, which can be potentially biased. This case-case-control study examining risk factors for enterococcal bacteraemia was conducted over 10 years (January 2000 to December 2009) in a tertiary, university-affiliated hospital. There were 440 episodes of enterococcal bacteraemia, 80 of which were caused by vancomycin-resistant Enterococcus (VRE). Two multivariable models were generated, comparing VRE and vancomycin-susceptible Enterococcus (VSE) with the same control group. VRE bacteraemia was associated with central venous catheter use (OR 11.6, 95% CI 2.6-51.5), neutropenia (OR 16.9, 95% CI 2.4-120.2), and allogenic bone marrow transplantation (OR 18.0, 95% CI 2.4-133.4). In contrast, VSE bacteraemia risk factors included: age (OR 1.0, 95% CI 1.0-1.1), exposure to metronidazole (OR 8.7, 95% CI 1.7-43.5), and gastrointestinal disease (OR 6.4, 95% CI 1.2-34.5). Meropenem use decreased the risk of VSE bacteraemia (OR 0.3, 95% CI 0.1-0.9). Hypoalbuminaemia was the only factor identified in both models (VRE, OR 6.0, 95% CI 1.7-21.1; VSE, OR 3.3, 95% CI 1.4-7.7). The absence of substantial overlap of risk factors for VRE and VSE argues in favour of differences in pathogenesis. These data suggest that environmental sources are more important in VRE bacteraemia. Endogenous sources, particularly the gastrointestinal tract, play a pivotal role in VSE bacteraemia. This study highlights the importance of infection control protocols to reduce the risk of VRE bacteraemia.

摘要

肠球菌是菌血症的重要病因。既往研究肠球菌菌血症危险因素的流行病学研究采用了传统的病例对照研究设计,这可能存在偏倚。这项研究对 2000 年 1 月至 2009 年 12 月期间在一所三级大学附属医院发生的肠球菌菌血症的危险因素进行了病例-病例对照研究。共发生 440 例肠球菌菌血症,其中 80 例由万古霉素耐药肠球菌(VRE)引起。比较 VRE 和万古霉素敏感肠球菌(VSE)与同一对照组,生成了两个多变量模型。VRE 菌血症与中心静脉导管使用(OR11.6,95%CI2.6-51.5)、中性粒细胞减少症(OR16.9,95%CI2.4-120.2)和同种异体骨髓移植(OR18.0,95%CI2.4-133.4)相关。相比之下,VSE 菌血症的危险因素包括:年龄(OR1.0,95%CI1.0-1.1)、甲硝唑暴露(OR8.7,95%CI1.7-43.5)和胃肠道疾病(OR6.4,95%CI1.2-34.5)。美罗培南的使用降低了 VSE 菌血症的风险(OR0.3,95%CI0.1-0.9)。低白蛋白血症是两个模型中唯一确定的因素(VRE,OR6.0,95%CI1.7-21.1;VSE,OR3.3,95%CI1.4-7.7)。VRE 和 VSE 的危险因素没有明显重叠,这表明发病机制存在差异。这些数据表明,环境来源在 VRE 菌血症中更为重要。内源性来源,特别是胃肠道,在 VSE 菌血症中起着关键作用。本研究强调了感染控制方案对于降低 VRE 菌血症风险的重要性。

相似文献

1
Differing risk factors for vancomycin-resistant and vancomycin-sensitive enterococcal bacteraemia.万古霉素耐药和敏感肠球菌菌血症的不同危险因素。
Clin Microbiol Infect. 2012 Apr;18(4):388-94. doi: 10.1111/j.1469-0691.2011.03591.x. Epub 2011 Aug 16.
2
Risk factors for vancomycin-resistant Enterococcus faecalis bacteremia in hospitalized patients: an analysis of two case-control studies.住院患者耐万古霉素粪肠球菌菌血症的危险因素:两项病例对照研究的分析
Am J Infect Control. 2006 Sep;34(7):447-51. doi: 10.1016/j.ajic.2005.08.015.
3
Case-case-control study on factors associated with vanB vancomycin-resistant and vancomycin-susceptible enterococcal bacteraemia.关于与耐万古霉素的vanB型和万古霉素敏感型肠球菌菌血症相关因素的病例-病例对照研究。
BMC Infect Dis. 2014 Jun 28;14:353. doi: 10.1186/1471-2334-14-353.
4
Enterococcal bacteraemia: factors influencing mortality, length of stay and costs of hospitalization.肠球菌菌血症:影响死亡率、住院时间和住院费用的因素。
Clin Microbiol Infect. 2013 Apr;19(4):E181-9. doi: 10.1111/1469-0691.12132. Epub 2013 Feb 7.
5
Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: comparison of clinical features and outcomes.耐万古霉素和对万古霉素敏感的肠球菌菌血症:临床特征与结局比较
Clin Infect Dis. 1998 May;26(5):1127-33. doi: 10.1086/520311.
6
Impact of vancomycin resistance on mortality among patients with neutropenia and enterococcal bloodstream infection.万古霉素耐药性对中性粒细胞减少症和肠球菌血流感染患者死亡率的影响。
J Infect Dis. 2005 Feb 15;191(4):588-95. doi: 10.1086/427512. Epub 2005 Jan 17.
7
Emergence of vancomycin-resistant Enterococcus bloodstream infections in southern Taiwan.台湾南部万古霉素耐药肠球菌血流感染的出现。
J Microbiol Immunol Infect. 2012 Jun;45(3):221-7. doi: 10.1016/j.jmii.2011.11.005. Epub 2012 May 10.
8
A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia.一项全国性、多中心、病例对照研究,比较耐万古霉素和对万古霉素敏感的肠球菌血症的危险因素、治疗方法及预后。
Diagn Microbiol Infect Dis. 2000 Mar;36(3):145-58. doi: 10.1016/s0732-8893(99)00136-4.
9
Epidemiology and clinical outcome of enterococcal bacteraemia in an acute care hospital.一家急症医院肠球菌血症的流行病学及临床结局
J Infect. 2006 May;52(5):383-6. doi: 10.1016/j.jinf.2005.07.011. Epub 2005 Oct 3.
10
Vancomycin-resistant enterococcal bacteraemia and daptomycin: are higher doses necessary?万古霉素耐药肠球菌菌血症与达托霉素:是否需要更高剂量?
J Antimicrob Chemother. 2011 Sep;66(9):2112-8. doi: 10.1093/jac/dkr255. Epub 2011 Jun 22.

引用本文的文献

1
Risk factors for vancomycin resistance in patients with bloodstream infections: an analysis of the Munich Multicentric Enterococci Cohort.血流感染患者中万古霉素耐药的危险因素:慕尼黑多中心肠球菌队列分析
Microbiol Spectr. 2025 Jul;13(7):e0005225. doi: 10.1128/spectrum.00052-25. Epub 2025 Jun 5.
2
Analysis of ESAC-Net/EARS-Net Data from 29 EEA Countries for Spatiotemporal Associations Between Antimicrobial Use and Resistance-Implications for Antimicrobial Stewardship?对来自29个欧洲经济区国家的ESAC-Net/EARS-Net数据进行分析,以研究抗菌药物使用与耐药性之间的时空关联——对抗菌药物管理有何启示?
Antibiotics (Basel). 2025 Apr 13;14(4):399. doi: 10.3390/antibiotics14040399.
3
Usefulness of a TDM-Guided Approach for Optimizing Teicoplanin Exposure in the Treatment of Secondary Bloodstream Infections Caused by Glycopeptide-Susceptible .
在治疗由糖肽类敏感菌引起的继发性血流感染中,采用治疗药物监测(TDM)指导的方法优化替考拉宁暴露的效用
Microorganisms. 2025 Jan 14;13(1):162. doi: 10.3390/microorganisms13010162.
4
98D alters gut microbial composition and function to improve DSS-induced colitis in mice.98D改变肠道微生物组成和功能以改善小鼠中由葡聚糖硫酸钠(DSS)诱导的结肠炎。
Heliyon. 2024 Mar 21;10(7):e28486. doi: 10.1016/j.heliyon.2024.e28486. eCollection 2024 Apr 15.
5
Gram-negative quorum sensing signalling enhances biofilm formation and virulence traits in gram-positive pathogen .革兰氏阴性群体感应信号增强革兰氏阳性病原体中的生物膜形成和毒力特性。
J Oral Microbiol. 2023 May 11;15(1):2208901. doi: 10.1080/20002297.2023.2208901. eCollection 2023.
6
Therapeutics for Vancomycin-Resistant Enterococcal Bloodstream Infections.万古霉素耐药肠球菌血流感染的治疗方法。
Clin Microbiol Rev. 2023 Jun 21;36(2):e0005922. doi: 10.1128/cmr.00059-22. Epub 2023 Apr 17.
7
Gut colonization with vancomicyn-resistant enterococci among patients with hematologic malignancies.血液系统恶性肿瘤患者中耐万古霉素肠球菌的肠道定植情况。
Gut Pathog. 2023 Mar 9;15(1):12. doi: 10.1186/s13099-023-00538-z.
8
Rapid Detection of Resistance Gene from Clinical Isolates Using Duplex Loop-Mediated Isothermal Amplification and Triplex PCR Assay.利用双重环介导等温扩增和三重 PCR 检测临床分离株中的耐药基因。
Biomed Res Int. 2022 Sep 20;2022:4384196. doi: 10.1155/2022/4384196. eCollection 2022.
9
Antibiotic Stewardship Related to Delayed Diagnosis and Poor Prognosis of Critically Ill Patients with Vancomycin-Resistant Enterococcal Bacteremia: A Retrospective Cohort Study.与耐万古霉素肠球菌菌血症重症患者延迟诊断及预后不良相关的抗生素管理:一项回顾性队列研究
Infect Drug Resist. 2022 Mar 1;15:723-734. doi: 10.2147/IDR.S354701. eCollection 2022.
10
Isolation and Characterization of a Phage to Control Vancomycin Resistant .一种用于控制耐万古霉素菌的噬菌体的分离与鉴定
Open Life Sci. 2018 Dec 31;13:553-560. doi: 10.1515/biol-2018-0066. eCollection 2018 Jan.